Frazier Life Sciences
Biotech Investor · 7 portfolio companies
Portfolio
7
Combined Value
$116.6M
Focus Areas
10
Top Stage
Pre-clinical
Investment Focus
Portfolio Companies
| Company | Valuation |
|---|---|
| enGene | $116.6M |
| Radionetics Oncology | — |
| Eccogene | — |
| Atom Bioscience | — |
| Hillstar Bio | — |
| Sonoma Biotherapeutics | — |
| IDEAYA Biosciences, Inc. | — |